Inside Gamma Delta T Cells with TC BioPharm’s CEO, Bryan Kobel
Inside Gamma Delta T Cells with TC BioPharm’s CEO, Bryan Kobel
TC BioPharm's CEO Bryan Kobel explains gamma delta t cells (GDT) in depth as well as the advantages of using GDT cells a... Read more
7 Jul 2022
•
33mins
Moving On from AAV with Poseida Therapeutics' CEO, Mark Gergen
Moving On from AAV with Poseida Therapeutics' CEO, Mark Gergen
Poseida Therapeutics is a broad platform technology company led by CEO, Mark Gergen. During this episode, Gergen explain... Read more
23 Jun 2022
•
27mins
Similar Podcasts
Business Of Biotech
The Readout Loud
Pivot
HBR IdeaCast
The Prof G Pod with Scott Galloway
The McKinsey Podcast
Planet Money
Biotech 2050 Podcast
Hidden Brain
Immune
Freakonomics Radio
The Ezra Klein Show
On Point
The Journal.
Goldman Sachs Exchanges
Inside the New Hybrid Roles for Cell Therapy Clinical Trials with Immatics' Michael Mehler
Inside the New Hybrid Roles for Cell Therapy Clinical Trials with Immatics' Michael Mehler
Autologous cell therapy clinical trials and products are very complex, and the stakeholder investment is diverse. Immati... Read more
9 Jun 2022
•
23mins
Moving to an Allogeneic RNA Cell Therapy Program with Cartesian Therapeutics' Dr. Metin Kurtoglu
Moving to an Allogeneic RNA Cell Therapy Program with Cartesian Therapeutics' Dr. Metin Kurtoglu
Dr. Metin Kurtoglu, COO at Cartesian Therapeutics, explains the clinical-stage biotech's autologous RNA cell therapies, ... Read more
26 May 2022
•
19mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Gene Therapy's Commercial Manufacturing Issues with Encoded Therapeutics' Andy Stober
Gene Therapy's Commercial Manufacturing Issues with Encoded Therapeutics' Andy Stober
Encoded Therapeutics' Chief Manufacturing Officer Andy Stober explains the unique commercial manufacturing issues in gen... Read more
12 May 2022
•
26mins
Inside CAR-T Therapy For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
Inside CAR-T Therapy For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
Amit Kumar, Ph.D., President and CEO at Anixa Biosciences details the company’s progress on its Phase 1 trial for ovaria... Read more
28 Apr 2022
•
18mins
Pivoting to Allogeneic CAR-T Therapies with Celyad Oncology’s CMO, Dr. Charlie Morris
Pivoting to Allogeneic CAR-T Therapies with Celyad Oncology’s CMO, Dr. Charlie Morris
Celyad Oncology’s CMO, Dr. Charlie Morris, shares the benefits and challenges of the allogeneic approach versus the auto... Read more
14 Apr 2022
•
25mins
Rocket Pharmaceuticals' CEO Dr. Gaurav Shah on FDA's Clinical Holds on Gene Therapy Trials
Rocket Pharmaceuticals' CEO Dr. Gaurav Shah on FDA's Clinical Holds on Gene Therapy Trials
Rocket Pharmaceuticals CEO Dr. Gaurav Shah offers his take on why gene therapy developers have been plagued by clinical ... Read more
31 Mar 2022
•
26mins
Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian
Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian
BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as... Read more
17 Mar 2022
•
25mins
Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma
Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma
Cue Biopharma's Anish Suri, Ph.D., explains why the clinical-stage biopharma is engineering a novel class of injectable ... Read more
3 Mar 2022
•
18mins
